Stock & Company Details
Arvinas Inc $ARVN
Price:
N/A
N/A
65M
$497M
52 Week High:
N/A
10 Day Average Volume:
N/A
49.25
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ARVN technical indicators
Latest Arvinas Inc (ARVN) indicator readings as of 2026-10-29.
ARVN's 14-day RSI is 55.4, in neutral territory. At $7.90 it is trading 18.6% below its 200-day moving average of $9.71, and below its 50-day average of $8.13. Price sits near the upper Bollinger Band ($6.84 to $7.94). ADX reads 13.9, indicating a range-bound market rather than a trend.
Overview
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
Finance Bot
Ask your questions
Start by typing a question below.
